Protalix BioTherapeutics Inc (PLX)
1.67
-0.02
(-1.18%)
USD |
NYAM |
Nov 21, 16:00
1.65
-0.02
(-1.20%)
After-Hours: 20:00
Protalix BioTherapeutics Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.7145 |
| March 31, 2024 | 0.6856 |
| December 31, 2023 | 0.6033 |
| September 30, 2023 | 0.5279 |
| June 30, 2023 | 0.5162 |
| March 31, 2023 | 28.04 |
| December 31, 2022 | -2.649 |
| September 30, 2022 | -2.442 |
| June 30, 2022 | -2.835 |
| March 31, 2022 | -3.735 |
| December 31, 2021 | -4.620 |
| September 30, 2021 | 145.80 |
| June 30, 2021 | 14.67 |
| March 31, 2021 | 3.818 |
| December 31, 2020 | -2.164 |
| September 30, 2020 | -1.735 |
| June 30, 2020 | -1.637 |
| March 31, 2020 | -1.816 |
| December 31, 2019 | -0.7858 |
| September 30, 2019 | -0.708 |
| June 30, 2019 | -0.732 |
| March 31, 2019 | -0.8131 |
| December 31, 2018 | -0.9071 |
| September 30, 2018 | -0.7281 |
| Date | Value |
|---|---|
| June 30, 2018 | -0.9429 |
| March 31, 2018 | -1.320 |
| December 31, 2017 | -1.772 |
| September 30, 2017 | -2.449 |
| June 30, 2017 | -2.800 |
| March 31, 2017 | -1.716 |
| December 31, 2016 | -7.353 |
| September 30, 2016 | -4.796 |
| June 30, 2016 | -9.067 |
| March 31, 2016 | 27.25 |
| December 31, 2015 | 6.631 |
| September 30, 2015 | -0.9892 |
| June 30, 2015 | -1.039 |
| March 31, 2015 | -1.105 |
| December 31, 2014 | -1.211 |
| September 30, 2014 | -1.412 |
| June 30, 2014 | -1.690 |
| March 31, 2014 | -2.000 |
| December 31, 2013 | -2.488 |
| September 30, 2013 | -4.007 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.5952 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.620
Minimum
Dec 2021
145.80
Maximum
Sep 2021
8.548
Average
-0.3929
Median
Debt to Equity Ratio Benchmarks
| Accuray Inc | 3.764 |
| Aethlon Medical Inc | -- |
| AIM ImmunoTech Inc | 0.9382 |
| Perspective Therapeutics Inc | -- |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 61.56M |
| Total Liabilities (Quarterly) | 29.13M |
| Shareholders Equity (Quarterly) | 32.44M |
| Current Ratio | 1.976 |
| Net Debt Paydown Yield | 5.36% |